Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma
2018 · Journal of Clinical Oncology · 252 citations
https://doi.org/10.1200/jco.18.00545
D
Daisuke Kawakita
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
2.7K
Citations
28
h-index
60
i10-index
Daisuke Kawakita is an academic researcher from Nagoya City University. The author has contributed to research in topics: Head and Neck Cancer Studies & Salivary Gland Tumors Diagnosis and Treatment & Ear and Head Tumors. The author has an h-index of 28, co-authored 126 publications.
ORCID: 0000-0003-3794-2790Papers by this author
worksClinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients
2016 · Annals of Surgical Oncology · 104 citations
https://doi.org/10.1245/s10434-015-5082-2
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
2020 · Scientific Reports · 56 citations
https://doi.org/10.1038/s41598-020-73965-6
The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
2017 · British Journal of Cancer · 19 citations
https://doi.org/10.1038/bjc.2017.383
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling
2022 · npj Precision Oncology · 16 citations
https://doi.org/10.1038/s41698-022-00324-1
Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
2022 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-022-18611-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat